Cargando…
Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation
PURPOSE: This study aimed to explore the underlying mechanisms of Shenyankangfu tablet (SYKFT) in the treatment of glomerulonephritis (GN) based on network pharmacology, machine learning, molecular docking, and experimental validation. METHODS: The active ingredients and potential targets of SYKFT w...
Autores principales: | Jin, Meiling, Ren, Wenwen, Zhang, Weiguang, Liu, Linchang, Yin, Zhiwei, Li, Diangeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590514/ https://www.ncbi.nlm.nih.gov/pubmed/34785888 http://dx.doi.org/10.2147/DDDT.S333209 |
Ejemplares similares
-
Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial
por: Kou, Jia, et al.
Publicado: (2014) -
Meta-analysis of the effectiveness and safety of Shenyankangfu tablets combined with losartan potassium in the treatment of chronic glomerulonephritis
por: Feng, Pan-Feng, et al.
Publicado: (2022) -
Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation
por: Ma, Chuanrui, et al.
Publicado: (2022) -
Exploring the Mechanism of Chuanxiong Rhizoma against Thrombosis Based on Network Pharmacology, Molecular Docking and Experimental Verification
por: He, Shasha, et al.
Publicado: (2023) -
Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation
por: Tan, Xin, et al.
Publicado: (2022)